Average Volume

Daily High

Daily Low

Share price from to

Latest ASX Announcements

No results

Investment Highlights

  • Focused on transforming mental healthcare through an AI-enabled smartphone application with breakthrough technology developed at Princeton University
  • Innovative approach leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old.
    • A significant advancement over traditional diagnoses occurring at around 5 years of age, often missing the crucial early window for effective intervention
  • Once approved by the regulators, this cutting-edge digital technology is poised to capture the imagination of both investors and major pharmaceutical companies, eager to embrace transformative solutions in healthcare
  • Led by an experienced management team and leading experts in the field of machine learning, autism and brain development bridging the most advanced technological innovations with groundbreaking scientific research
    • Chaired by Brian Leedman, an experienced biotechnology entrepreneur and founder of ResApp Health, a digital diagnostic company recently acquired by Pfizer


23 October 2023
Vertical Events & RIU Conferences
07 May 2022
BlinkLab Presentation at BioNJ BioPartnering Conference
02 December 2021
Sam Wang and Henk-Jan Boele: Smartphone-based screening for autism, neurobehavioral conditions



27 March 2024
The Australian
ResApp founder back to ASX with BlinkLab | The Australian


02 March 2024
The West
Start-up’s app test to detect ADHD and autism in kids
28 February 2024
Investing News Network
BlinkLab Limited: Transforming Mental Healthcare through Mobile-based AI
05 February 2024
Investing News Network
Study Shows BlinkLab’s Potential for Mobile-based Neurobehavioural Testing
19 January 2024
Mirage News
Morgan, Leedman Join BlinkLab Board for AI Autism Detection